united healthcare coverage for glp 1 GLP-1 drugs present an uncertain opportunity Noom GLP1 Weight Loss

GLP-1 agonists are proven to reduce incidence of cardiovascular disease, the number 1 fatal disease in the United States

Lacosamide: an investigational drug for adjunctive treatment of partial-onset seizures

Over a 52- to 68-week period, clinical trials have shown average weight loss ranging from 11% to 17% of initial body weight

Read on to learn about the most common causes of this uncomfortable condition, and how to treat them

Whether the issue is erectile dysfunction, low libido, declining testosterone levels, or a combination of factors, identifying the root cause is the first step

The acute nature of its action demands precision in dosing to avoid unwanted complications